Citation

van Asselt AD, Dirksen CD, Arntz A, Severens JL. Eur. Psychiatry 2007; 22(6): 354-361.

Affiliation

Department of Clinical Epidemiology and MTA, University Hospital Maastricht, Maastricht, The Netherlands. avas@kemta.azm.nl

Copyright

(Copyright © 2007, Elsevier Publishing)

DOI

10.1016/j.eurpsy.2007.04.001

PMID

17544636

Abstract

BACKGROUND: Borderline personality disorder (BPD) is a highly prevalent, chronic condition. Because of its very problematic nature BPD is expected to be associated with substantial societal costs, although this has never been comprehensively assessed. OBJECTIVE: Estimate the societal cost of BPD in the Netherlands. STUDY DESIGN: We used a prevalence-based bottom-up approach with a sample of 88 BPD patients who enrolled in a multicenter clinical trial comparing two kinds of outpatient psychotherapy. Costs were assessed by means of a structured interview, covering all healthcare costs, medication, informal care, productivity losses, and out-of-pocket expenses. Only BPD-related costs were included. All costs were expressed in Euros for the year 2000. A bootstrap procedure was performed to determine statistical uncertainty. PATIENTS: All patients had been diagnosed with BPD using DSM-IV criteria. Mean age was 30.5 years and 92% was female. RESULTS: Based on a prevalence of 1.1% and an adult population of 11,990,942, we derived that there were 131,900 BPD patients in the Netherlands. Total bootstrapped yearly cost of illness was 2,222,763,789 euros (1,372,412,403-3,260,248,300 euros), only 22% was healthcare-related. Costs per patient were 16,852 euros. CONCLUSIONS: Although healthcare costs of non-institutionalized Borderline patients might not be disproportionate, total societal costs are substantial.

Language: en